Host Responses to Intestinal Microbial Antigens in Gluten-Sensitive Mice
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND AIMS: Excessive uptake of commensal bacterial antigens through a permeable intestinal barrier may influence host responses to specific antigen in a genetically predisposed host. The aim of this study was to investigate whether intestinal barrier dysfunction induced by indomethacin treatment affects the host response to intestinal microbiota in gluten-sensitized HLA-DQ8/HCD4 mice. METHODOLOGY/PRINCIPAL FINDINGS: HLA-DQ8/HCD4 mice were sensitized with gluten, and gavaged with indomethacin plus gluten. Intestinal permeability was assessed by Ussing chamber; epithelial cell (EC) ultra-structure by electron microscopy; RNA expression of genes coding for junctional proteins by Q-real-time PCR; immune response by in-vitro antigen-specific T-cell proliferation and cytokine analysis by cytometric bead array; intestinal microbiota by fluorescence in situ hybridization and analysis of systemic antibodies against intestinal microbiota by surface staining of live bacteria with serum followed by FACS analysis. Indomethacin led to a more pronounced increase in intestinal permeability in gluten-sensitized mice. These changes were accompanied by severe EC damage, decreased E-cadherin RNA level, elevated IFN-gamma in splenocyte culture supernatant, and production of significant IgM antibody against intestinal microbiota. CONCLUSION: Indomethacin potentiates barrier dysfunction and EC injury induced by gluten, affects systemic IFN-gamma production and the host response to intestinal microbiota antigens in HLA-DQ8/HCD4 mice. The results suggest that environmental factors that alter the intestinal barrier may predispose individuals to an increased susceptibility to gluten through a bystander immune activation to intestinal microbiota.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mouse models indicate that gluten can induce activation of innate immunity, increased small intestinal permeability,160 neuro-muscular dysfunction159 and dysbiosis161 in the absence of autoimmunity.”
From Intestinal microbiota in functional bowel disorders: a Rome foundation report (2013) · cites this paper as [161]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610
Pfaffl, M. W. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.9.e36 · Cited by 7,376 · cited 1×
“Statistical analysis was performed using ANOVA with post-hoc test for simple and multiple comparisons, respectively. Nonparametric statistical significance of relative RNA expression was calculated with REST software”
MethodAmann, R. I., Binder, B. J., Olson, R. J., Chisholm, S. W., Devereux, R., & Stahl, D. A. (1990) · Applied and Environmental Microbiology · doi:10.1128/aem.56.6.1919-1925.1990 · Cited by 4,021 · cited 1×
“EUB 338 probe, targeting conserved sequences within the bacterial domain, was used as positive control [55].”
MethodGreen, P. H. R., & Jones, R. (2006) · Cited by 2,453
Marsh, M. N. (1992) · PubMed · Cited by 1,985
Gluten, major histocompatibility complex, and the small intestine
Marsh, M. N. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91819-p · Cited by 1,693 · cited 1×
“celiac disease-DQ2 and DQ8 [3–7].”
Induction of Protective IgA by Intestinal Dendritic Cells Carrying Commensal Bacteria
Macpherson, A. J., & Uhr, T. (2004) · Science · doi:10.1126/science.1091334 · Cited by 1,584 · cited 1×
“SPF mice have been shown to be systemically ignorant to their intestinal microbiota due to the geographic and functional separation between the mucosal and systemic immune system by the mesenteric lymph nodes (MLN) [17,38].”
BackgroundWallner, G., Amann, R., & Beisker, W. (1993) · Cytometry · doi:10.1002/cyto.990140205 · Cited by 1,212 · cited 1×
“NON EUB 338 probe was used as negative control to eliminate the background fluorescence [ 56 ].”
MethodRostom, A., Murray, J. A., & Kagnoff, M. F. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.10.004 · Cited by 840 · cited 2×
“of CD varies considerably from severe to subtle, and that the clinical expression is not restricted to the presence of mucosal atrophy [1,2].”
Self-citationTlaskalová-Hogenová, H., Štěpánková, R., Hudcovic, T., Tučková, L., Cukrowska, B., Lodinová-Žádnı́ková, R., Kozáková, H., Rossmann, P., Bártová, J., Sokol, D., et al. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.02.005 · Cited by 755 · cited 1×
“Although the role of the intestinal microbiota in other chronic diseases of the gut is clearly established”
BackgroundFasano, A., Not, T., Wang, W., Uzzau, S., Berti, I., Tommasini, A., & Goldblum, S. E. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02169-3 · Cited by 670 · cited 1×
“apical junctional structure [22–25], and can also be transported by an abnormal transcellular route [26].”
BackgroundAlterations in intestinal permeability
Arrieta, M. C., Bistritz, L., & Meddings, J. B. (2006) · Gut · doi:10.1136/gut.2005.085373 · Cited by 634 · cited 1×
“Under normal conditions, the intestinal epithelium acts as a protective barrier restricting transport of luminal antigens, and only allows small and selective quantities to permeate the mucosa [16–18].”
BackgroundDrago, S., El Asmar, R., Di Pierro, M., Grazia Clemente, M., Sapone, A. T. A., Thakar, M., Iacono, G., Carroccio, A., D'Agate, C., Not, T., et al. (2006) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520500235334 · Cited by 502 · cited 1×
“apical junctional structure [22–25], and can also be transported by an abnormal transcellular route [26].”
BackgroundFasano, A., & Shea-Donohue, T. (2005) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0259 · Cited by 484 · cited 1×
“The intestinal epithelium regulates permeation of luminal antigens and excessive immune activation within the mucosa [16,34].”
BackgroundBacterial translocation from the gastrointestinal tract
Berg, R. (1995) · Trends in Microbiology · doi:10.1016/s0966-842x(00)88906-4 · Cited by 444 · cited 1×
“growth and translocation [27,29].”
Clemente, M. G. (2003) · Gut · doi:10.1136/gut.52.2.218 · Cited by 412 · cited 1×
“apical junctional structure [22–25], and can also be transported by an abnormal transcellular route [26].”
BackgroundImbalance in the composition of the duodenal microbiota of children with coeliac disease
Nadal, I., Donant, E., Ribes-Koninckx, C., Calabuig, M., & Sanz, Y. (2007) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47410-0 · Cited by 396 · cited 1×
“An altered microbiota composition has been reported in patients with CD compared to healthy controls [49,50].”
BackgroundSelf-citationCeliac disease: pathogenesis of a model immunogenetic disease
Kagnoff, M. F. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30253 · Cited by 386 · cited 1×
“The presence of HLA-DQ2/DQ8 genes are necessary but not sufficient for the development of CD [13], as up to 25–40% of general populations in United States carry these genes and eat gluten, but do not develop a celiac lesion [2,13], thus raising the possibility of contributing environmental and genetic risk factors yet…”
BackgroundMatysiak-Budnik, T., Moura, I. C., Arcos-Fajardo, M., Lebreton, C., Ménard, S., Candalh, C., Ben-Khalifa, K., Dugave, C., Tamouza, H., van Niel, G., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071204 · Cited by 313 · cited 2×
“intestinal commensals [26].”
BackgroundResistance of germfree rats to indomethacin-induced intestinal lesions
Robert, A., & Asano, T. (1977) · Prostaglandins · doi:10.1016/0090-6980(77)90178-2 · Cited by 312 · cited 1×
“Germ-free rats have been reported to have a higher threshold for intestinal damage after indomethacin administration compared to specific pathogen-free (SPF) rats [35].”
BackgroundBetween Celiac Disease and Irritable Bowel Syndrome: The “No Man's Land” of Gluten Sensitivity
Verdu, E. F., Armstrong, D., & Murray, J. A. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.188 · Cited by 283 · cited 1×
“celiac disease-DQ2 and DQ8 [3–7].”
Self-citationNewberry, R. D., Stenson, W. F., & Lorenz, R. G. (1999) · Nature Medicine · doi:10.1038/11341 · Cited by 264 · cited 2×
“Consequently, COX-2 inhibitors such as indomethacin may exacerbate the immune response to dietary antigens [33].”
BackgroundFord, A. C., Forman, D., Bailey, A. G., Axon, A. T. R., & Moayyedi, P. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01740.x · Cited by 233 · cited 1×
“A recent epidemiological study has determined that consumption of nonsteroidal anti-inflammatory drugs (NSAIDs) is a risk factor for the development of irritable bowel syndrome [41].”
BackgroundLindfors, K., Blomqvist, T., Juuti-Uusitalo, K., Stenman, S., Venäläinen, J., Mäki, M., & Kaukinen, K. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2008.03635.x · Cited by 204 · cited 1×
“Splenocyte proliferation, cell cultures and cytokine analysis Peptic-tryptic digests of gliadin (PT-gliadin) was prepared as described previously [54].”
MethodCompartmentalization of the Mucosal Immune Responses to Commensal Intestinal Bacteria
MACPHERSON, A. J., & UHR, T. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1309.005 · Cited by 197 · cited 1×
“SPF mice have been shown to be systemically ignorant to their intestinal microbiota due to the geographic and functional separation between the mucosal and systemic immune system by the mesenteric lymph nodes (MLN) [17,38].”
BackgroundSigthorsson, G., Simpson, R. J., Walley, M., Anthony, A., Foster, R., Hotz–Behoftsitz, C., Palizban, A., Pombo, J., Watts, J., Morham, S. G., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.33647 · Cited by 191
Presence of Bacteria and Innate Immunity of Intestinal Epithelium in Childhood Celiac Disease
Forsberg, G., Fahlgren, A., Horstedt, P., Hammarstrom, S., Hernell, O., & Hammarstrom, M.-L. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04157.x · Cited by 187 · cited 1×
“Recent findings, however, report presence of rod-shaped bacteria in the mucosa of active and non-active celiac patients but not in healthy controls [43].”
BackgroundSander, G. R., Cummins, A. G., & Powell, B. C. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.07.066 · Cited by 180 · cited 1×
“apical junctional structure [22–25], and can also be transported by an abnormal transcellular route [26].”
Backgroundvan Elburg, R. M., Uil, J. J., Mulder, C. J., & Heymans, H. S. (1993) · Gut · doi:10.1136/gut.34.3.354 · Cited by 179 · cited 1×
“and their healthy relatives, suggesting that in a proportion of cases, intestinal barrier abnormalities may predate overt inflammation”
BackgroundSanz, Y., Sánchez, E., Marzotto, M., Calabuig, M., Torriani, S., & Dellaglio, F. (2007) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2007.00337.x · Cited by 173 · cited 2×
“Flow cytometry detections were performed using anEPICSH XL-MCL flow cytometer (Beckman Coulter, Florida, USA) as previously described [58].”
MethodSelf-citationCeliac Disease Without Villous Atrophy
Kaukinen, K., Mãki, M., Partanen, J., Sievãnen, H., & Collin, P. (2001) · Digestive Diseases and Sciences · doi:10.1023/a:1010729207320 · Cited by 169
The functional interactions of commensal bacteria with intestinal secretory IgA
Macpherson, A. J., & Slack, E. (2007) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3282f0d012 · Cited by 158 · cited 1×
“The clinical relevance of the loss of systemic ignorance against the intestinal microbiota remains to be established, however, systemic priming to the commensal flora represents a significant shift in the normal relationship between host and commensal bacteria [40].”
BackgroundSelf-citationGreen, P. H. R., & Jabri, B. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.57.051804.122404 · Cited by 154
Guo, X., Rao, J. N., Liu, L., Zou, T.-T., Turner, D. J., Bass, B. L., & Wang, J.-Y. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00015.2003 · Cited by 153
Black, K. E., Murray, J. A., & David, C. S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5595 · Cited by 150 · cited 2×
“Male transgenic mice expressing HLA-DQ8 genes (HLA-DQA1*0301; HLADQb1*0302) in the absence of endogenous mouse class II genes or HLA-DQ8/HCD4 double transgenic mice were used [8,51].”
BackgroundMethodSelf-citationPolymeric Binders Suppress Gliadin-Induced Toxicity in the Intestinal Epithelium
Pinier, M., Verdu, E. F., Nasser–Eddine, M., David, C. S., Vézina, A., Rivard, N., & Leroux, J. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.09.016 · Cited by 144 · cited 1×
“This model has proven useful for the preclinical testing of novel experimental therapies designed to block gluten-induced mucosal pathology [12].”
BackgroundSelf-citationA new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice
Marietta, E., Black, K., Camilleri, M., Krause, P., Rogers, R. S., David, C., Pittelkow, M. R., & Murray, J. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421055 · Cited by 144 · cited 1×
“HLA-DQ8/ HCD4 or single HLA-DQ8 transgenic mice that are sensitized with gluten develop an immune response to gliadin that involves both the adaptive and innate immune system [8–11].”
BackgroundSelf-citationSokol, H., Lepage, P., Seksik, P., Doré, J., & Marteau, P. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.02600-05 · Cited by 140 · cited 1×
“This proportion was corrected by subtracting the background fluorescence obtained with the negative control probe NON EUB 338 [57,58].”
MethodVerdu, E. F., Huang, X., Natividad, J., Lu, J., Blennerhassett, P. A., David, C. S., McKay, D. M., & Murray, J. A. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00225.2007 · Cited by 125 · cited 3×
“It is unclear, however, if these changes are primary or secondary to the functional gut abnormalities observed in the model [ 11 ].”
BackgroundInfluentialSelf-citationMino-Kenudson, M. A., & Lauwers, G. Y. (2003) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200309000-00007 · Cited by 107 · cited 1×
“celiac disease-DQ2 and DQ8 [3–7].”
Cross linking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac disease
Dieterich, W., Esslinger, B., Trapp, D., Hahn, E., Huff, T., Seilmeier, W., Wieser, H., & Schuppan, D. (2006) · Gut · doi:10.1136/gut.2005.069385 · Cited by 85 · cited 2×
“Indeed, celiac patients have been shown to increase systemic titres of IgA antibodies against collagen [15].”
BackgroundBjarnason, I., & Peters, T. J. (1984) · Gut · doi:10.1136/gut.25.2.145 · Cited by 81 · cited 1×
“In contrast, increased intestinal permeability has been demonstrated in patients with active CD [19,20] and their healthy relatives, suggesting that in a proportion of cases, intestinal barrier abnormalities may predate overt inflammation [21].”
BackgroundPorras, M., Martín, M. T., Yang, P.-C., Jury, J., Perdue, M. H., & Vergara, P. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000231571.88806.62 · Cited by 76 · cited 2×
“Indomethacin has been used at higher doses as a model of inflammatory bowel disease (IBD) [27,28], and has been shown to compromise epithelial barrier integrity and function, induce motility changes, and promote small intestinal bacterial overgrowth and translocation [27,29].”
BackgroundSelf-citationIntestinal permeability in patients with coeliac disease and dermatitis herpetiformis.
Bjarnason, I., Marsh, M. N., Price, A., Levi, A. J., & Peters, T. J. (1985) · Gut · doi:10.1136/gut.26.11.1214 · Cited by 74 · cited 1×
“In contrast, increased intestinal permeability has been demonstrated in patients with active CD [19,20] and their healthy relatives, suggesting that in a proportion of cases, intestinal barrier abnormalities may predate overt inflammation [21].”
BackgroundAdjuvant effect of Lactobacillus casei in a mouse model of gluten sensitivity
D’Arienzo, R., Maurano, F., Luongo, D., Mazzarella, G., Stefanile, R., Troncone, R., Auricchio, S., Ricca, E., David, C. S., & Rossi, M. (2008) · Immunology Letters · doi:10.1016/j.imlet.2008.04.006 · Cited by 66 · cited 1×
“at the time of mucosal sensitization with gliadin and cholera toxin exacerbates the Th1 response induced in the model”
BackgroundSelf-citationMallant–Hent, R. C., Mary, B., von Blomberg, E., ksel, Z. Y., Wahab, P. J., Gundy, C. M., Meyer, G. A., & Mulder, C. J. J. (2005) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200601000-00013 · Cited by 59 · cited 1×
“The disappearance of anti-Saccaromyces cervisiae-antibodies (ASCA) after a gluten-free diet suggests that healing of mucosal lesions is related to microbial sero-markers [45].”
BackgroundDalby, A. B., Frank, D. N., St. Amand, A. L., Bendele, A. M., & Pace, N. R. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.00378-06 · Cited by 56 · cited 1×
“Thus, dysmotility induced by gluten sensitization [11] or indomethacin [36], and/or the ability of indomethacin to induce small intestinal dysbiosis [36, 37 ] may facilitate bacterial translocation.”
BackgroundGluten Sensitivity in a Subset of Children With Insulin Dependent Diabetes Mellitus
Troncone, R., Franzese, A., Mazzarella, G., Paparo, F., Auricchio, R., Coto, I., Mayer, M., & Greco, L. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07301.x · Cited by 51 · cited 1×
“celiac disease-DQ2 and DQ8 [3–7].”
Senger, S., Maurano, F., Mazzeo, M. F., Gaita, M., Fierro, O., David, C. S., Troncone, R., Auricchio, S., Siciliano, R. A., & Rossi, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.8087 · Cited by 51 · cited 1×
“HLA-DQ8/ HCD4 or single HLA-DQ8 transgenic mice that are sensitized with gluten develop an immune response to gliadin that involves both the adaptive and innate immune system [8–11].”
BackgroundSelf-citationAshorn, S., Raukola, H., Välineva, T., Ashorn, M. H., Wei, B., Braun, J. G., Rantala, I. S., Kaukinen, K., Luukkaala, T. H., Collin, P., et al. (2008) · Journal of Clinical Immunology · doi:10.1007/s10875-008-9200-9 · Cited by 38 · cited 1×
“Interestingly, microbial seropositivity was also present in gluten-sensitive patient with no evidence of active CD. However, increasing age was associated with seroreactivity for anaerobic bacteria, possibly reflecting exposure to different environmental antigens with longer duration of disease [ 44 ].”
BackgroundCheng, S., Smart, M., Hanson, J. A., & David, C. S. (2003) · Journal of Autoimmunity · doi:10.1016/s0896-8411(03)00120-3 · Cited by 33 · cited 1×
“Male transgenic mice expressing HLA-DQ8 genes (HLA-DQA1*0301; HLADQb1*0302) in the absence of endogenous mouse class II genes or HLA-DQ8/HCD4 double transgenic mice were used [8,51].”
MethodSelf-citationIntestinal motor disorders associated with cyclical bacterial overgrowth in a rat model of enteritis
Porras, M., Martín, M. T., Soler, M., & Vergara, P. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00513.2003 · Cited by 32 · cited 1×
“Thus, dysmotility induced by gluten sensitization [11] or indomethacin [36], and/or the ability of indomethacin to induce small intestinal dysbiosis [36,37] may facilitate bacterial translocation.”
BackgroundA Role for Bacteria in Celiac Disease?
Sollid, L. M., & Gm, G. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04158.x · Cited by 28
Exploring the Iceberg-the Spectrum of Celiac Disease
Cronin, C. C., & Shanahan, F. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07308.x · Cited by 22 · cited 1×
“of CD varies considerably from severe to subtle, and that the clinical expression is not restricted to the presence of mucosal atrophy [1,2].”
BackgroundImmunologically Mediated Transport of Ions and Macromolecules
Yu, L. C., & Perdue, M. H. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05248.x · Cited by 20 · cited 1×
“The intestinal epithelium regulates permeation of luminal antigens and excessive immune activation within the mucosa [16,34].”
BackgroundBarshack, I., Goldberg, I., Chowers, Y., Weiß, B., Horowitz, A., & Kopolovic, J. (2001) · Journal of Clinical Pathology · doi:10.1136/jcp.54.9.684 · Cited by 19
Celiac Disease as a Model of Gastrointestinal Inflammation
Sollid, L. M. (2005) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200504001-00025 · Cited by 9 · cited 1×
“the threshold for immune cell activation [46,47].”
Furst, S. M., Komocsar, W. J., Khan, K. N. M., White, K. L., Peachee, V. L., & Mennear, J. H. (2005) · Journal of Immunotoxicology · doi:10.1080/15476910490916828 · Cited by 7 · cited 1×
“NSAIDs have been shown to reduce the phagocytic properties of macrophages [39].”
Background
Research works printed but not linked: 2
- Sander GR Cummins AG Powell BC 2005 Rapid disruption of intestinal barrier fucntion by gliadin nvolves altered expression of apical junctional proteins. FEBS 579; 21 4851 4855 16099460 · DOI · Paper page
- Sanz Y Sanchez E Marzotto M Calabuig M Torriani S 2007 Differences in faecal bacterial communities in coeliac and healthy children as detected by PCR and denaturing gradient gel electrophoresis. FEMS Immunol Med Microbiol 51 562 568 17919298 · DOI · Paper page
Cited by
The intestinal epithelial barrier: a therapeutic target?
Odenwald, M. A., & Turner, J. R. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.169 · Cited by 1,288
Intestinal microbiota in functional bowel disorders: a Rome foundation report
Simrén, M., Barbara, G., Flint, H. J., Spiegel, B. M. R., Spiller, R. C., Vanner, S., Verdu, E. F., Whorwell, P. J., & Zoetendal, E. G. (2013) · Gut · doi:10.1136/gutjnl-2012-302167 · Cited by 939
Paracellular permeability and tight junction regulation in gut health and disease
Horowitz, A., Chanez-Paredes, S. D., Haest, X., & Turner, J. R. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00766-3 · Cited by 687
de Magistris, L., Familiari, V., Pascotto, A., Sapone, A., Frolli, A., Iardino, P., Carteni, M., De Rosa, M., Francavilla, R., Riegler, G., et al. (2010) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181dcc4a5 · Cited by 546
Modulation of intestinal barrier by intestinal microbiota: Pathological and therapeutic implications
Natividad, J. M. M., & Verdu, E. F. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2012.10.007 · Cited by 525
Self-citation
Metadata
- Authors
- Natividad, J. M., Huang, X., Slack, E., Jury, J., Sanz, Y., David, C., Denou, E., Yang, P., Murray, J., McCoy, K. D., & Verdú, E. F.
- Affiliations
- McMaster University (CA)
- Consejo Superior de Investigaciones Científicas (ES)
- Mayo Clinic (US)
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-07-31
- Volume
- 4
- Issue
- 7
- Pages
- e6472
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2715133
- OpenAlex
- W2161402890
- Cited by
- 73
- References
- 58
- Citations by year
- 2024: 2 · 2023: 10 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 3 · 2018: 2 · 2017: 2 · 2016: 6 · 2015: 10 · 2014: 8 · 2013: 7 · 2012: 9
- FWCI
- 6.38
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Bern Open Repository and Information System (University of Bern) (submittedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Repository for Publications and Research Data (ETH Zurich) (submittedVersion, cc-by)
- ETH Zürich Research Collection (cc-by)
- Funders
- McMaster University
- Canadian Celiac Association
- Canadian Association of Gastroenterology
- Canadian Institutes of Health Research
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK071003, R01DK71003)
- Topics
- Health Sciences › Medicine › Gastroenterology › Celiac Disease Research and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- celiac disease, gluten sensitivity, intestinal permeability, intestinal barrier dysfunction, indomethacin, epithelial damage, E-cadherin, interferon-gamma
- MeSH terms
- Animals, Antigens, Bacterial, Glutens, HLA-DQ Antigens, Indomethacin, Intestines, RNA, Messenger, Cadherins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.